Criteria Bio Ventures leads a €3 million investment in Adaptam Therapeutics

by CriteriaCaixa

This financing round will enable Adaptam to continue advancing its programs and initiate the preclinical phase across multiple oncology indications. As part of the round, Salvatore Cappadona, PhD, and...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra advises Precinmac on its acquisi...

by Alantra

This transaction reinforces Alantra’s continued momentum in Aerospac...

Photos Stream